Atracef T 250mg/31.25mg Injection
Marketer
Ashlife Healthcare
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Atracef T 250mg/31.25mg Injection
Cefatrizine 250mg/31.25mg injection combines two antibiotics to combat diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly under medical guidance; adhere to all scheduled doses, completing the entire course even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes, alongside possible injection site reactions (redness, swelling, pain) which usually subside. Escalating side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (rashes, itching, swelling, breathing difficulties). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is typically unaffected, refrain from driving if drowsiness or dizziness occur.
Uses of Atracef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Atracef T 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified nurse; self-medication is strictly prohibited.
Common Side effects of Atracef T 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Atracef T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strongly discouraged.
How Atracef T 250mg/31.25mg Injection works:
Atracef T Injection (250mg/31.25mg) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thereby broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Atracef T 250mg/31.25mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Atracef T (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials are currently insufficient.
Breast feedingSAFE IF PRESCRIBED
Cefadroxil and sulbactam injection (250mg/31.25mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Atracef T 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
The use of Atracef T 250mg/31.25mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification of Atracef T 250mg/31.25mg Injection might be necessary. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Atracef T 250mg/31.25mg Injection in patients with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Atracef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Atracef T 250mg/31.25mg Injection requires immediate physician consultation.
Facts to Know About Atracef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Antimicrobial agents |
3,018 People bought this recently